Identification of CASZ1 nuclear export signal (NES) reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma

Por Liu, Zhihui, Lam, Norris, Wang, Evelyn, Virden, Ryan A., Pawel, Bruce, Attiyeh, Edward F., Maris, John M., Thiele, Carol J.
Publicado no Oncogene (2016)

A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

Por Cole, Kristina A., Attiyeh, Edward F., Mosse, Yael P., Laquaglia, Michael J., Diskin, Sharon J., Brodeur, Garrett M., Maris, John M.
Publicado em 2008

Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis

Por Volchenboum, Samuel L., Li, Cheng, Li, Shuli, Attiyeh, Edward F., Reynolds, C. Patrick, Maris, John M., Look, A. Thomas, George, Rani E.
Publicado em 2009

Integrative genomic analyses of sporadic clear cell Renal Cell Carcinoma define disease subtypes and potential new therapeutic targets

Por Dondeti, Vijay R., Wubbenhorst, Bradley, Lal, Priti, Gordan, John D., D'Andrea, Kurt, Attiyeh, Edward F., Simon, M. Celeste, Nathanson, Katherine L.
Publicado em 2011

Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy

Por Attiyeh, Edward F., Diskin, Sharon J., Attiyeh, Marc A., Mossé, Yaël P., Hou, Cuiping, Jackson, Eric M., Kim, Cecilia, Glessner, Joseph, Hakonarson, Hakon, Biegel, Jaclyn A., Maris, John M.
Publicado em 2009

Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy

Por Attiyeh, Edward F., Diskin, Sharon J., Attiyeh, Marc A., Mossé, Yaël P., Hou, Cuiping, Jackson, Eric M., Kim, Cecilia, Glessner, Joseph, Hakonarson, Hakon, Biegel, Jaclyn A., Maris, John M.
Publicado em 2009

Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays

Por George, Rani E., Attiyeh, Edward F., Li, Shuli, Moreau, Lisa A., Neuberg, Donna, Li, Cheng, Fox, Edward A., Meyerson, Matthew, Diller, Lisa, Fortina, Paolo, Look, A. Thomas, Maris, John M.
Publicado em 2007

Outcome of High-Risk Stage 3 Neuroblastoma with Myeloablative Therapy and 13-cis-Retinoic Acid: A Report from the Children’s Oncology Group

Por Park, Julie R., Villablanca, Judith G., London, Wendy B., Gerbing, Robert B., Haas-Kogan, Daphne, Stanton Adkins, E., Attiyeh, Edward F., Maris, John M., Seeger, Robert C., Patrick Reynolds, C., Matthay, Katherine K.
Publicado em 2009

Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: A report from the Children’s Oncology G...

Por Vujkovic, Marijana, Attiyeh, Edward F., Ries, Rhonda E., Horn, Michelle, Goodman, Elizabeth K., Ding, Yang, Kavcic, Marko, Alonzo, Todd A., Gerbing, Robert B., Hirsch, Betsy, Raimondi, Susana, Gamis, Alan S., Meshinchi, Soheil, Aplenc, Richard
Publicado no Cancer Genet (2015)

Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma

Por Chand, Damini, Yamazaki, Yasuo, Ruuth, Kristina, Schönherr, Christina, Martinsson, Tommy, Kogner, Per, Attiyeh, Edward F., Maris, John, Morozova, Olena, Marra, Marco A., Ohira, Miki, Nakagawara, Akira, Sandström, Per-Erik, Palmer, Ruth H., Hallberg, Bengt
Publicado em 2013

Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci

Por Nguyễn, Lễ B., Diskin, Sharon J., Capasso, Mario, Wang, Kai, Diamond, Maura A., Glessner, Joseph, Kim, Cecilia, Attiyeh, Edward F., Mosse, Yael P., Cole, Kristina, Iolascon, Achille, Devoto, Marcella, Hakonarson, Hakon, Li, Hongzhe K., Maris, John M.
Publicado em 2011

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Por Diskin, Sharon J, Capasso, Mario, Schnepp, Robert W, Cole, Kristina A, Attiyeh, Edward F, Hou, Cuiping, Diamond, Maura, Carpenter, Erica L, Winter, Cynthia, Lee, Hanna, Jagannathan, Jayanti, Latorre, Valeria, Iolascon, Achille, Hakonarson, Hakon, Devoto, Marcella, Maris, John M
Publicado em 2012

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis

Por Schnepp, Robert W., Khurana, Priya, Attiyeh, Edward F., Raman, Pichai, Chodosh, Sara E., Oldridge, Derek A., Gagliardi, Maria E., Conkrite, Karina L., Asgharzadeh, Shahab, Seeger, Robert C., Madison, Blair B., Rustgi, Anil K., Maris, John M., Diskin, Sharon J.
Publicado no Cancer Cell (2015)

Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): a report from the Pediatric Preclinical Testing Program

Por Attiyeh, Edward F., Maris, John M., Lock, Richard, Reynolds, C. Patrick, Kang, Min H., Carol, Hernan, Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Wu, Jianrong, Landesman, Yosef, Shacham, Sharon, Lyalin, Dmitry, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
Publicado no Pediatr Blood Cancer (2015)

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

Por Cole, Kristina A., Huggins, Jonathan, Laquaglia, Michael, Hulderman, Chase E., Russell, Mike R., Bosse, Kristopher, Diskin, Sharon J., Attiyeh, Edward F., Sennett, Rachel, Norris, Geoffrey, Laudenslager, Marci, Wood, Andrew C., Mayes, Patrick A., Jagannathan, Jayanti, Winter, Cynthia, Mosse, Yael P., Maris, John M.
Publicado em 2011

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism

Por Mandriota, Stefano J., Valentijn, Linda J., Lesne, Laurence, Betts, David R., Marino, Denis, Boudal-Khoshbeen, Mary, London, Wendy B., Rougemont, Anne-Laure, Attiyeh, Edward F., Maris, John M., Hogarty, Michael D., Koster, Jan, Molenaar, Jan J., Versteeg, Rogier, Ansari, Marc, Gumy-Pause, Fabienne
Publicado no Oncotarget (2015)

Dual CDK4/CDK6 Inhibition Induces Cell Cycle Arrest and Senescence in Neuroblastoma

Por Rader, JulieAnn, Russell, Mike R., Hart, Lori S., Nakazawa, Michael S., Belcastro, Lili T., Martinez, Daniel, Li, Yimei, Carpenter, Erica L., Attiyeh, Edward F., Diskin, Sharon J., Kim, Sunkyu, Parasuraman, Sudha, Caponigro, Giordano, Schnepp, Robert W., Wood, Andrew C., Pawel, Bruce, Cole, Kristina A., Maris, John M.
Publicado em 2013

Identification of ALK as the Major Familial Neuroblastoma Predisposition Gene

Por Mossë, Yalë P, Laudenslager, Marci, Longo, Luca, Cole, Kristina A, Wood, Andrew, Attiyeh, Edward F, Laquaglia, Michael J, Sennett, Rachel, Lynch, Jill E, Perri, Patrizia, Laureys, Geneviève, Speleman, Frank, Hakonarson, Hakon, Torkamani, Ali, Schork, Nicholas J, Brodeur, Garrett M, Tonini, Gian Paolo, Rappaport, Eric, Devoto, Marcella, Maris, John M
Publicado em 2008

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Por Capasso, Mario, Devoto, Marcella, Hou, Cuiping, Asgharzadeh, Shahab, Glessner, Joseph T., Attiyeh, Edward F., Mosse, Yael P., Kim, Cecilia, Diskin, Sharon J., Cole, Kristina A., Bosse, Kristopher, Diamond, Maura, Laudenslager, Marci, Winter, Cynthia, Bradfield, Jonathan P., Scott, Richard H., Jagannathan, Jayanti, Garris, Maria, McConville, Carmel, London, Wendy B., Seeger, Robert C., Grant, Struan F. A., Li, Hongzhe, Rahman, Nazneen, Rappaport, Eric, Hakonarson, Hakon, Maris, John M.
Publicado em 2009

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform that Influences Neuroblastoma Susceptibility and Oncogenicity

Por Bosse, Kristopher R., Diskin, Sharon J., Cole, Kristina A., Wood, Andrew C., Schnepp, Robert W., Norris, Geoffrey, Nguyen, Le B., Jagannathan, Jayanti, Laquaglia, Michael, Winter, Cynthia, Diamond, Maura, Hou, Cuiping, Attiyeh, Edward F., Mosse, Yael P., Pineros, Vanessa, Dizin, Eva, Zhang, Yongqiang, Asgharzadeh, Shahab, Seeger, Robert C., Capasso, Mario, Pawel, Bruce R., Devoto, Marcella, Hakonarson, Hakon, Rappaport, Eric F., Irminger-Finger, Irmgard, Maris, John M.
Publicado em 2012